Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c213ba9952360f439567152e047b18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1916cbc3943c56f9c2e5daf9c5b37a4a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-40 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0476 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-044 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
filingDate |
2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73cfb671b1bc7575f018e21881ad5aef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4ae9bb2420c02c9b3e03f0548fd4d60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a65d95b59a506a7ebcbfe76806f639cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84af7971620438bebb2fdce64243a2ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_046ab19924c42ae454ca7ffab7d83f50 |
publicationDate |
2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015023873-A1 |
titleOfInvention |
Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging |
abstract |
The invention provides, in some embodiments, methods relating to assessing increased risk of developing atrial fibrillation (AF), and/or the likelihood of responding to particular AF therapies using imaging agents comprising an MMP inhibitor linked to an imaging moiety. The invention further provides methods for evaluating the presence of the risk of developing other cardiovascular conditions and assessing the effectiveness of treatment or other intervention for such conditions by determining MMP levels. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017177144-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11286251-B2 |
priorityDate |
2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |